As told to Parliament (March 14, 2023): After Uzbekistan cough syrup deaths, Centre cautioned pharma units
All that was discussed in the House through the day
AMR Awareness Week: Way forward for pharma companies to ensure antibiotics manufacturing doesn’t drive resistance
The risk of AMR posed by the release of antibiotic manufacturing waste can be prevented
Pharma is getting high on marijuana
As drug companies develop cannabis-based medicines for serious illnesses, generic firms are trying to get into the act
India to set up 10 pharma clusters across country
The move will reduce cost of production of medicines by up to 25 per cent
Ranbaxy effect: Indian government defends pharma industry
Few isolated cases cannot undermine well regulated system, says commerce ministry
Sun-Ranbaxy merger: CCI says deal may hurt competition, seeks public opinion
The merger would lead to creation of the world's fifth-largest maker of generic drugs
Sun Pharma, Novartis settle lawsuit over Glivec
Sun Pharma allowed to launch generic version of anti-leukamia drug next year
Maharashtra bans anti-tick medication temporarily
26 heads of cattle killed after being administered injection in Parbhani district
Pharma lobby obtains stay on Centre’s drug price control order
Drug manufacturers also trying to scuttle government’s drug pricing policy
A patent triumph of public interest
New flexibilities make public interest safeguards integral to drug patent rights
Three pharma units under scanner for exposing workers to polyacrylate hazard
Gujarat High court directs medical check-up of all employees
Government withdraws NPPA’s power to fix prices of non-essential medicines
Prices of cardiac, diabetes, HIV/AIDS drugs likely to be affected
Indian company gets licence to manufacture and sell patented cancer drug
This is the first-ever compulsory licence given to a generic drug company
Budget 2023-24 live: Greening the economy is among top 7 priorities, says Nirmala Sitharaman in budget speech
Live updates from the budget speech February 1, 2023
US is finally trying to rein in drug giants
Biden government’s push to get Big Pharma to reduce the astronomical rates of prescription medicines is significant
More give than take in secret trade deals
The tight secrecy over trade negotiations means citizens are not privy to the deals that affect them directly
When Big Pharma has all the answers
IFPMA, the biopharma trade body, has made its claim clear: COVID-19 vaccine management should be left to these handful of companies; and all …
Trial by hire
Laissez-faire in clinical research has unleashed a ruthless profit-making machine blind to notions of justice or equity. It is time to rein in …
Indian pharma firms receive 34% of FDA warnings this year
These warnings were for misbranding, selling unapproved medicines and violating Current Good Management Practices
National List of Essential Medicines: 34 drugs enlisted in update after 7 years
The latest National List of Essential Medicines features 384 medicines, drops 26 old ones
Why Americans pay more for prescription drugs than anywhere else globally
The root of the problem is a patent system that allows pharma companies to keep out competition and keep prices sky high
Antimicrobial resistance: Here is how pharma companies can reduce antibiotic pollution in effluents
There is a high risk of antibiotic residues entering the environment from wastewater used in manufacturing pharmaceuticals
FDI in pharma: Cabinet clears KKR investments in two Indian drug firms
Union health and commerce ministries have been opposing such investment without safeguards for acquisition of domestic critical care pharma firms
US sound and fury over drug prices
The US Senate is outraged by the rapacious pricing policy of drug firms but will it act to reform the system?
Sun Pharma to buy troubled giant Ranbaxy
The combined entity will create India’s largest pharma company and world’s fifth-largest specialty generics company